Source: Health Canada shortage reports · Updated Sep 4, 2026
Some Levetiracetam products are in shortage in Canada (12 of 48 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
An anticonvulsant used to treat seizures in epilepsy.
Products affected
12 / 48
In shortage since
Apr 1, 2018
Reports on file
139
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
M-LEVETIRACETAM
750MG · TABLET · MANTRA PHARMA INC
DIN 02524589 · since Feb 19, 2024, no end estimate · Delay in shipping of the drug.
Active shortage
M-LEVETIRACETAM
500MG · TABLET · MANTRA PHARMA INC
DIN 02524570 · since Feb 19, 2024, no end estimate · Delay in shipping of the drug.
Active shortage
NAT-LEVETIRACETAM
500MG · TABLET · NATCO PHARMA (CANADA) INC
DIN 02440210 · since Jul 1, 2025, est. end Jun 30, 2026 · Disruption of the manufacture of the drug.
Active shortage
NAT-LEVETIRACETAM
250MG · TABLET · NATCO PHARMA (CANADA) INC
DIN 02440202 · since Jul 1, 2025, est. end Jun 30, 2026 · Disruption of the manufacture of the drug.
Active shortage
NAT-LEVETIRACETAM
750MG · TABLET · NATCO PHARMA (CANADA) INC
DIN 02440229 · since Apr 8, 2025, est. end Jun 30, 2026 · Disruption of the manufacture of the drug.
Active shortage
ACH-LEVETIRACETAM
750MG · TABLET · ACCORD HEALTHCARE INC
DIN 02399792 · since Jun 20, 2025, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortage
ACH-LEVETIRACETAM
250MG · TABLET · ACCORD HEALTHCARE INC
DIN 02399776 · since Mar 21, 2025, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortage
ACH-LEVETIRACETAM
500MG · TABLET · ACCORD HEALTHCARE INC
DIN 02399784 · since Jun 28, 2024, no end estimate · Requirements related to complying with good manufacturing practices.
Active shortage
BIO-LEVETIRACETAM
500MG · TABLET · BIOMED PHARMA
DIN 02450356 · since Dec 31, 2019, no end estimate · Disruption of the manufacture of the drug.
Active shortage
BIO-LEVETIRACETAM
750MG · TABLET · BIOMED PHARMA
DIN 02450364 · since Apr 1, 2018, no end estimate · Delay in shipping of the drug.
Active shortage
BIO-LEVETIRACETAM
250MG · TABLET · BIOMED PHARMA
DIN 02450348 · since Apr 1, 2018, no end estimate · Delay in shipping of the drug.
Active shortage
LEVETIRACETAM
750MG · TABLET · LABORATOIRE RIVA INC
DIN 02474484 · since Oct 5, 2018, no end estimate · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Levetiracetam is currently affected by 12 active shortage reports filed with Health Canada by MANTRA PHARMA INC, NATCO PHARMA (CANADA) INC, ACCORD HEALTHCARE INC, BIOMED PHARMA and 1 others.
The reported causes are: delay in shipping of the drug; disruption of the manufacture of the drug; requirements related to complying with good manufacturing practices. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Levetiracetam is classified under “ANTIEPILEPTICS” (ATC N03AX).
Recent changes
Sep 4, 2026
Shortage resolved
Sep 4, 2026
Shortage resolved
Sep 4, 2026
Shortage resolved
Aug 6, 2026
New report filed
Jul 30, 2026
New report filed
Jul 23, 2026
Estimated end date moved earlier : Sep 11, 2026 → Sep 4, 2026
Common questions
What is Levetiracetam used for?
An anticonvulsant used to treat seizures in epilepsy.
When will Levetiracetam be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Levetiracetam in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Possible alternatives in the same class (antiepileptics)
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.